Stocklytics Platform
CHE
Chemed
CHE62
$563.35arrow_drop_up1.48%$8.37
CHE
CHE62

$563.35

arrow_drop_up1.48%
Key Stats
Open$563.35
Prev. Close$563.62
EPS19.89
Next Earnings DateJun 20, 2025
LOWHIGH
Day Range563.35
563.35
52 Week Range497.37
654.62
Ratios
EPS19.89
Fundamentals
Industry average yield2.87%
Last Dividend pay dateMar 14, 2025

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell

Analyst rating

An aggregate view of professional's ratings.

—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell

Stock Performance

CHE-
US Healthcare Sector-
US Market-
check_circle

CHE / Market

CHE exceeded the US Market which returned 0.95% over the last twenty four hours.
warning

CHE / Healthcare Sector

CHE lose to the US Healthcare sector which returned 2.47% over the last twenty four hours.

Chemed (CHE) Statistics

Chemed Corp (CHE) is a publicly traded company that operates in the healthcare services sector. As of the latest available data, CHE has a market capitalization of over $8 billion. The stock has performed well in recent years, outperforming the sector average. CHE's stock price has increased by more than 50% in the past five years, while the sector average has only seen a growth of around 30%. This positive stock performance can be attributed to strong fundamentals and impressive financial metrics.
When looking at CHE's valuation metrics, we can see that the stock is trading at a reasonable multiple to its earnings. The price-to-earnings ratio (P/E ratio) for CHE is around 30, which is slightly higher than the sector average. This suggests that investors are willing to pay a premium for CHE's strong earnings growth prospects. In terms of revenue per share, CHE has been consistently increasing its top line. The company's revenue per share is currently around $80. This indicates that CHE is generating significant revenue for every outstanding share of stock.
add Chemed to watchlist

Keep an eye on Chemed

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Chemed (CHE) stock's performance compared to its sector and the market over the past year?

Over the past year, Chemed (CHE) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 18.84%, Chemed has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 34.48%, it has fallen short of the market average. This comparison highlights Chemed's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Chemed (CHE) stock?

The PE (Price to Earnings) ratio of Chemed (CHE) is currently 28.32. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Chemed (CHE) stock?

The Earnings Per Share (EPS) for Chemed (CHE), calculated on a diluted basis, is $19.89. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Chemed (CHE) stock?

The operating margin for Chemed (CHE) is 17.79%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Chemed (CHE) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Chemed (CHE) is $467.38M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Chemed (CHE) have?

Chemed (CHE) has a total debt of $140.84M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$37.51M.

Take Your Investments to a Whole New Level